Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Cytek Biosciences, Inc.
  6. News
  7. Summary
    CTKB   US23285D1090

CYTEK BIOSCIENCES, INC.

(CTKB)
  Report
Delayed Nasdaq  -  05/26 04:00:01 pm EDT
9.710 USD   +4.86%
05/24Cytek Biosciences Receives CE Marking for cFluor Reagents, TBNK Kit in Europe
MT
05/24Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
GL
05/16Piper Sandler Adjusts Price Target on Cytek Biosciences to $12 From $17, Reiterates Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cytek Biosciences, Inc.(NasdaqGS:CTKB) added to S&P Global BMI Index

12/20/2021 | 12:00am EDT
share with twitter
share with LinkedIn
share with facebook

Cytek Biosciences, Inc.(NasdaqGS:CTKB) added to S&P Global BMI Index


© S&P Capital IQ 2021
All news about CYTEK BIOSCIENCES, INC.
05/24Cytek Biosciences Receives CE Marking for cFluor Reagents, TBNK Kit in Europe
MT
05/24Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
GL
05/16Piper Sandler Adjusts Price Target on Cytek Biosciences to $12 From $17, Reiterates Ove..
MT
05/12Morgan Stanley Lowers Price Target for Cytek Biosciences to $11 From $18, Maintains Equ..
MT
05/12INSIDER SELL : Cytek Biosciences
MT
05/12Goldman Sachs Lowers Cytek Biosciences Price Target to $12 From $14, Buy Rating Maintai..
MT
05/12CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
05/11Cytek Biosciences Posts Flat Adjusted EPS, Higher Revenue for Q1; Sees 2022 Revenue at ..
MT
05/11Cytek Biosciences Seeks M&A
CI
05/11TRANSCRIPT : Cytek Biosciences, Inc., Q1 2022 Earnings Call, May 11, 2022
CI
More news
Analyst Recommendations on CYTEK BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2022 242 M - -
Net income 2022 1,98 M - -
Net cash 2022 366 M - -
P/E ratio 2022 555x
Yield 2022 -
Capitalization 1 244 M 1 244 M -
EV / Sales 2022 3,63x
EV / Sales 2023 4,05x
Nbr of Employees 511
Free-Float 82,5%
Chart CYTEK BIOSCIENCES, INC.
Duration : Period :
Cytek Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CYTEK BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 9,26 $
Average target price 11,67 $
Spread / Average Target 26,0%
EPS Revisions
Managers and Directors
Wen Bin Jiang President, Chief Executive Officer & Director
Patrik Sebastian Jeanmonod Chief Financial Officer
Ming Yan Director & Chief Technology Officer
Melik Ulusu VP-Operations & Integrated Supply Chain
Jack T. Ball Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CYTEK BIOSCIENCES, INC.-43.26%1 244
THERMO FISHER SCIENTIFIC-17.75%209 146
DANAHER CORPORATION-23.92%179 203
INTUITIVE SURGICAL, INC.-38.05%79 897
SIEMENS HEALTHINEERS AG-18.32%64 383
EDWARDS LIFESCIENCES CORPORATION-25.24%60 217